In vitro formation of S-nitrosohemoglobin in red cells by inducible nitric oxide synthase  by Mamone, Gianfranco et al.
In vitro formation of S-nitrosohemoglobin in red cells by inducible nitric
oxide synthase
Gianfranco Mamonea, Nicola Sannolob, Antonio Malornia;c, Pasquale Ferrantia;d;*
aCentro Internazionale di Servizi di Spettrometria di Massa, CNR, via Pansini 5, 80131 Naples, Italy
bIstituto di Medicina del Lavoro, II Universita', Piazza Miraglia, Naples, Italy
cIstituto Chimica Molecole Interesse Biologico, CNR, Arco Felice, Naples, Italy
dDipartimento di Scienza degli Alimenti, Universita' di Napoli ‘Federico II’, 80100 Portici, Naples, Italy
Received 14 September 1999; received in revised form 30 October 1999
Edited by Pierre Jolles
Abstract The present study demonstrates that NO produced in
vitro by inducible nitric oxide synthase in red cells can convert
hemoglobin contained in the red cells to S-nitrosohemoglobin.
Experiments carried out either in the absence or in the presence
of a low molecular weight thiol, such as cysteine, showed that in
the first case the target of NO is heme-Fe2+. On the contrary,
in the presence of cysteine, the first step is the formation of
S-nitrosocysteine, followed by transfer of the NO group to a
particular cysteine residue of L-globin, cysteine 93. These results
confirm previous data indicating the preferential formation of
S-nitrosohemoglobin at that site by chemical methods [Ferranti
et al. (1997) FEBS Lett. 400, 17^24], and the existence of a
physiological mechanism of inactivation for NO circulating in
blood. The analysis of S-nitrosohemoglobin can also allow the
quantification of the NO levels in blood to be applied for in vitro
and in vivo measurements.
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1. Introduction
The interaction of nitric oxide (NO) with proteins plays a
critical role in several physiological systems extending from
blood pressure regulation to neurotransmission [1^3]. In addi-
tion, NO produced in infected and in£amed tissue can con-
tribute to the process of carcinogenesis [4,5]. The targets of
NO on proteins are Cys and bound metals such as heme-Fe2
(for a review see [6]), through which NO exerts its e¡ects by
covalently modifying or oxidizing critical thiols or transition
metals in proteins. Although much work has been performed
in characterizing the NO-Fe2 interaction [7,8], there are con-
siderably less data on the NO-Cys interactions. One reason is
the labile nature of S-nitrosothiols (RSNOs) which are unsta-
ble in aqueous solution. It has been assumed that the lability
of RSNOs is due to their propensity to undergo homolytic
cleavage of the S^N bond with release of NO [9].
Recent studies have demonstrated the biological importance
of the interaction of RSNOs, which can be considered as NO
donors, with proteins at the level of Cys residues [10,11]. Low
mass RSNOs are one class of endogenous compounds capable
of protein S-nitrosylation as demonstrated in the case of he-
moglobin (Hb) [12]. The L-chain of Hb contains a highly
reactive thiol group at position 93 [13], which is conserved
among mammalian species, although its function remains un-
known. It has been recently proposed that its interaction with
endogenous RSNOs to form S-nitrosohemoglobin (HbSNO)
[12] may serve for regulation of blood pressure and facilitates
e⁄cient delivery of oxygen to tissues [14]. Recently, structural
data have been produced to support the preferential in vitro
formation of HbSNO at LCys-93 [15] at RSNO concentra-
tions close to that in vivo, thus indicating that physiological
HbSNO is S-nitrosylated at that site. Other forms of HbSNO,
where nitrosylated cysteines are also LCys-112 and KCys-104,
are produced in vitro at higher RSNO concentrations [15].
Current methods of RSNO colorimetric detection require
large amount of sample. Other spectrophotometric methods
exist including UV, IR and NMR techniques. Again sample
amount, purity, and quantitation are serious di⁄culties asso-
ciated with these methods. Electrospray ionization mass spec-
trometry (ES/MS) can detect RSNOs in very small amount
and can determine the stoichiometry of substitution [15,16].
Furthermore, this method allows coupling to high perform-
ance liquid chromatography which enables on-line quantita-
tive analysis and peptide mapping of sites of RSNO forma-
tion.
We have used this approach to demonstrate the formation
of HbSNO either in hemolysate or in whole red cells by action
of inducible nitric oxide synthase (iNOS) on the same Hb
residue (LCys-93). At the same time, it was possible to quan-
tify the amount of HbSNO. The approach can be extended to
the characterization of S-nitrosoproteins from di¡erent sour-
ces. This makes possible structural studies on extremely labile
species such as protein nitrosothiols.
2. Materials and methods
2.1. Materials
Blood samples were collected from non-pathologic subjects imme-
diately prior to their use for in vitro incubation in anti-coagulation
tubes containing 20 mM EDTA, and stored at 4‡C. All reagents were
obtained from Sigma Chemical Co. (St. Louis, MO, USA). Recombi-
nant mouse macrophage iNOS, no. 60802, from Cayman Chemical
Co. (Ann Arbor, MI, USA), was stored in HEPES, pH 7.4, contain-
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ing 10% glycerol. HPLC-grade solvents were from Carlo Erba (Milan,
Italy). 2.1 mm inner diameter columns, 25 cm long, for both analytical
and micropreparative scale procedures were used. The columns were
Vydac (Hesperia, CA, USA) C4 (214TP52) for globin analysis, and
Vydac C18 (218TP52) for peptide mapping. The HPLC apparatus was
constituted by a Hewlett-Packard series 1100 modular system with an
integrated diode array detector. The e¥uent from HPLC separation
was on-line injected into a Platform (Micromass, UK) mass spectrom-
eter equipped with a standard electrospray source via a 75 Wm i.d.
fused silica capillary. The Masslynx (Micromass, UK) software fur-
nished by the instrument manufacturer was used for data processing.
2.2. Preparation of red cell samples
Aliquots of 1 ml of blood were centrifuged at 3000 rpm. After
discarding plasma, erythrocytes were washed three times with 2 ml
isotonic 0.9% NaCl solution by centrifugation at 3000 rpm for 15 min
at 4‡C. Two ml of packed erythrocytes were suspended in 2 ml of
20 mM sodium dihydrogen phosphate, pH 7.4. Samples were aerated
with a gentle stream of air for 5 min to fully convert Hb in the oxy-
form. This procedure resulted in a Hb concentration of about 2 mM.
2.3. Preparation of the hemolysate samples
Hemolysates were prepared by suspending 1 ml of washed eryth-
rocytes in 1 ml of deionized water. After occurrence of hemolysis,
sample was separated by centrifugation (10 000 rpm, 20 min at 4‡C
twice), and the supernatant fraction used at once or stored frozen
(320‡C for up to a week or 370‡C for up to 3 months) until required.
This hemolysate had a Hb concentration of about 1 mM. The sample
was aerated with a gentle stream of air for 5 min. This oxy-Hb was
estimated by SDS-gel electrophoresis and by isoelectric focusing (IEF)
to be about 95% pure and prepared immediately prior to its use [17].
2.4. Enzymatic synthesis of S-nitrosohemoglobin
Before its use, activity of iNOS was quantitated spectrophotometri-
cally using the oxyhemoglobin assay [18]. This assay measures the
reaction of nitric oxide produced with oxyhemoglobin to yield methe-
moglobin (metHb) (O= 60 000 M31 cm31 at 401 nm). One unit of
enzyme produces 1 nmol of nitric oxide per min at 37‡C in 50 mM
HEPES (pH 7.4) containing 1 mM L-arginine, 0.1 mM magnesium
acetate, 0.1 mM NADPH, 12 WM tetrahydrobiopterin, 12 WM FAD,
12 WM FMN and 170 WM DTT. These conditions were employed for
checking the enzyme activity.
In a ¢rst experiment, 3 Wl of freshly prepared 0.2 mM hemolysate
(previously £ushed with a gentle air stream) and 1 unit of iNOS were
contemporary incubated for 30 min at 37‡C in 1 ml 50 mM HEPES
(pH 7.4) containing 1 mM L-arginine, 0.1 mM magnesium acetate,
0.1 mM NADPH, 12 WM tetrahydrobiopterin, 12 WM FAD, 12 WM
FMN and 170 WM DTT (incubation bu¡er).
Two further incubations were then carried out. In the ¢rst of them,
a solution of freshly prepared hemolysate, containing 0.2 mM Hb,
was prepared in the incubation bu¡er (1 ml) containing also 1 mM
Cys. The enzyme (1 unit) was added and the reaction allowed to take
place for 30 min. In the second experiment, the incubation bu¡er
(1 ml) also containing 1 mM Cys was added with the enzyme, and
this reaction mixture was left at 37‡C for 30 min, after which the
hemolysate (3 Wl, 0.2 mM) was added and the incubation carried
out for 10 min. All the reactions were monitored by absorbance at
401 nm. To avoid HbSNO degradation, the reactions were stopped by
directly adding 200 Wl 5% TFA, after which liquid chromatography-
electrospray mass spectrometry (LC/ES/MS) analysis was carried out.
For any experiment a blank sample was prepared in which all the
above components were present except the enzyme solution.
For the production of HbSNO in red cells, we followed the same
procedure as in hemolysate, but the HEPES concentration was
100 mM (to obtain the isotonic condition) and the reaction was
stopped by lysis of red cells with 1 ml distilled water and the sample
¢ltered. After the spectrophotometric assay, the solution was added
with 200 Wl TFA 5% and analyzed by LC/ES/MS.
2.5. Liquid chromatography-mass spectrometry of S-nitrosohemoglobin
Globin chains from HbSNO were puri¢ed by RP-HPLC using the
procedure developed by Shelton et al. [19] with the following modi¢-
cations: liquid chromatography was carried out with a 2.1 mm
i.d.U250 mm, C4, 5 Wm (Vydac) reverse-phase column, in the follow-
ing bu¡er system: bu¡er A: 80:20:0.1 (v:v:v) water:acetonitrile:TFA
and bu¡er B: 40:60:0.07 (v:v:v) water:acetonitrile:TFA. The £ow
rate was 0.1 ml/min. The column was equilibrated at 52% bu¡er B.
After applying the sample (50 Wg of freshly synthesized HbSNO dis-
solved in 20 Wl volume) bu¡er B was raised to 66% over 50 min. The
electrospray needle was set at a voltage of 3.6 kV, the cone voltage at
20 V, the sheath gas pressure (nitrogen 99.997%) at 75 psi, the source
temperature at 100‡C. The mass spectra were scanned from 1600 to
600 U at a scan cycle of 5 s/scan. Nitrosylated K- and L-globin and the
derived peptides were identi¢ed by a +29 mass shift with respect to
native chains. A rough estimate of the proportion of native and nitro-
sylated globins/peptides was obtained from the relative intensity of the
ionization current of molecules through the reconstructed spectrum.
Indeed, the ionization level is dependent on the nature of the com-
pound. From the native and nitrosylated species, however, being very
close in composition and structure, we have inferred that the compar-
ison of the ionization level could give a valuable estimation of their
relative amount. Therefore, quantitative analysis of components was
carried out by integration of the multiply charged ions for the single
species. For both K- and L-globin chains, the ions carrying 13^22
charges, which in the analytical conditions used were the most intense,
were chosen. This quantitative analysis was carried out at low cone
voltage (20 V) and temperature (100‡C), which minimize nitrosothiol
decomposition in the ion source, furnishing the best quantitative data
[15].
2.6. LC/ES/MS peptide mapping
For peptide mapping, globins were digested with pepsin (porcine
stomach mucosa, Sigma). Samples were dissolved in 100 Wl of 5%
formic acid and a substrate: enzyme ratio 15:1 (w/w) was used. After
incubation at 37‡C for 1 h, the reaction was stopped by freezing at
320‡C. Liquid chromatography was performed using a 2.1 mm
i.d.U250 mm, C18 5 Wm (Vydac) reverse-phase column with a £ow
rate of 0.1 ml/min. Solvent A was 0.03% TFA (v/v) in water; solvent
B was 0.02% TFA in acetonitrile. The column was equilibrated at 5%
solvent B. Separation of the peptides was e¡ected with a gradient 5^
40% solvent B over 50 min. The mass spectra were scanned from 1800
to 400 U at scan cycle of 5 s/scan. The components were identi¢ed by
the use of a dedicated software program (Peptide Tools, Hewlett-
Packard). For single ion monitoring (SIM) analysis, the doubly-
and triply-charged ions (m/z 1041.7 and m/z 694.8 respectively) of
the nitrosylated peptide L(89^105) were monitored.
3. Results
In Fig. 1 the spectrophotometric analysis of an hemolysate
sample incubated with iNOS in di¡erent conditions is re-
ported. The direct incubation of a hemolysate sample with
iNOS (panel a) led to a rapid increase in the absorbance at
401 nm, which corresponded to the conversion of Hb to
metHb. In panel b the same experiment was carried out in
the presence of 1 mM Cys. The curve was much less sloping,
indicating that the formation of metHb by reaction of Hb
with NO was slower in the presence of Cys. When Cys was
added to the reaction mixture containing iNOS 30 min before
adding the hemolysate (panel c), no absorbance increase was
observed, which demonstrated that the NO formed was not
available for reaction with heme and no metHb was produced.
The three samples were then analyzed by LC/MS at the end
of the reaction. In the ¢rst two samples, only native K- and
L-globins were identi¢ed on the basis of the respective molec-
ular weight [15]. In the third experiment the mass measured
for the K-chain (15 126.5 þ 1.1) perfectly matched that of the
native globin (15 126.4). On the contrary, of the two species
present at the L-position (not shown), the ¢rst one was the
native L-globin (15 868.5 þ 1.4, expected mass 15 867.2) where-
as the second had a mass of 15 897.8 þ 1.1 with a shift of +29
units compared with that measured for the L-globin, indicat-
ing that a single NO moiety was bound to the globin.
The spectrophotometric and MS data, taken together, dem-
onstrated that (i) when Hb was directly exposed to NO pro-
FEBS 22960 26-11-99
G. Mamone et al./FEBS Letters 462 (1999) 241^245242
duced by iNOS, only formation of metHb was observed.
When the same reaction was performed in the presence of a
low mass thiol, such as Cys, the oxidation of Hb to metHb
was slower because part of the NO was removed as S-nitro-
socysteine. On the contrary, when preliminary incubation of
Cys with iNOS was performed, no metHb and the contempo-
rary synthesis of HbSNO was observed.
The same experiments were then carried out on a red cell
sample. In this case only the LC/MS analysis was performed,
because the presence of intact cells made not possible spec-
trophotometric analysis. The reaction pattern was comparable
to that obtained using the hemolysate. In particular (Fig. 2),
the formation of nitrosylated L-globin was observed only
when preliminary incubation of iNOS was performed in the
presence of Cys. The relative amount of the native and nitro-
sylated L-globin was 1:0.15.
For a full characterization of the nitrosylated species, the
nitrosylated Hb samples were digested with pepsin in order to
perform the peptide map of the modi¢ed globins. Pepsin was
chosen as the proteolytic agent because it allowed us incuba-
tion in acidic bu¡er where nitrosylated species are more stable
[9,15]. The LC/ES/MS separation of the peptic digest of the
nitrosylated globin chains is shown in Fig. 3. HPLC peaks
could be assigned to the peptides within the globin sequence
on the basis of the measured molecular weight. It was possible
to check out the entire sequence of the two globins in mixture
by this procedure. The only nitrosylated peptide detected was
peptide L(89^105).
The peak at 36.5 min in the chromatogram of Fig. 3 con-
tained peptide L(89^105) (molecular weight 2052.3) containing
LCys-93, with a molecular weight of 2052.6 þ 0.2 (identi¢ed by
the doubly- and triply-charged ions at m/z 1027.2 and m/z
685.1 respectively). A novel peak was also detected at higher
retention time (38.0 min) containing a peptide of mass
2081.3 þ 0.7 (identi¢ed by the doubly- and triply-charged
ions at m/z 1041.7 and m/z 694.8 respectively). This value
corresponded to the mass of peptide 89^105 increased by
29 mass units, due to nitrosylation at the level of LCys-93.
Fig. 1. Spectrophotometric analysis of the hemolysate incubated in the presence of iNOS. Panel a: hemolysate incubated directly with iNOS.
The rapid conversion of Hb to metHb is observed. Panel b: hemolysate and Cys incubated simultaneously with iNOS. The much slower forma-
tion of metHb is observed. Panel c: hemolysate added 30 min after incubation of Cys with iNOS. No conversion of metHb is observed.
Fig. 2. ES/MS spectrum in the transformed mass scale of nitrosy-
lated L-globin. Cys was incubated in the presence of iNOS for
30 min, then red cells were added and, after 10 min, the reaction
products were analyzed by mass spectrometry.
Fig. 3. LC/ES/MS analysis of the peptic digest of globin chains
from a red cell sample incubated with iNOS. The peptide L(89^105),
eluted at 36.5 min and with a molecular weight of 2052.6, is indi-
cated. The nitrosylated peptide L(89^105), indicated by an arrow, is
present at 38.0 min and has a molecular weight of 2081.3. In the in-
set the SIM chromatogram for m/z 1041.7 and m/z 694.8, corre-
sponding to the doubly- and triply-charged ions of the nitrosylated
peptide, is shown.
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This was veri¢ed with the same procedure applied for the
synthesis of HbSNO by chemical methods [15].
The same analysis was carried out in SIM mode (Fig. 3,
inset). The peaks corresponding to the multicharged ions of
the nitrosylated peptide L(89^105) were used for the acquis-
ition. In this way it would be possible to obtain a better
measure for the detection and the quantitative analysis of
the nitrosylated species at lower levels, as expected in physio-
logical conditions.
4. Discussion
This work demonstrates the formation of HbSNO in vitro
either in hemolysate and in intact red cells by action of iNOS.
This process takes place via low mass nitrosothiol intermedi-
ates, like S-nitrosocysteine. In this work we have analyzed a
model system in order to determine whether the NO produced
by iNOS in blood were able to convert Hb to HbSNO. To
ascertain this, the experiments were ¢rst performed on an
hemolysate sample, to monitor spectrophotometrically and
mass spectrometrically the formation of metHb. The same
experiments were then carried out on red cells to con¢rm
that the reaction gave the same products when iNOS (and
therefore the NO produced externally to the red cells) was
not in close contact with Hb. In this last case the experiments
were monitored only by mass spectrometry due to the high
background in the spectrophotometric assay. Our data indi-
cate that following the production of NO in the presence of a
low-mass thiol system, such as Cys, HbSNO is formed in the
red cells in vitro. It is possible that HbSNO is produced in
vivo through a similar process. According to this hypothesis
NO, once formed, can immediately react with nucleophiles
such as the thiol group of Cys, either before or after entering
the red cell membrane, and the resulting S-nitrosocysteine can
act as an NO exchanger for Hb.
In the red cells several small molecular mass thiol systems
are present, Cys and gluthatione [20,21] among others, which
can be converted to nitrosothiols and consequently act as NO
donors [22]. This means that the production of HbSNO can
be mediated by a series of molecules via thiol exchange.
In the experiment we have carried out in the absence of
Cys, the NO produced only metHb (Fig. 1, panel a). When
the Cys was added to red cells in the course of the NO pro-
duction, an intermediate situation was observed in which the
formation of metHb was slower, because part of the NO had
already reacted with Cys (Fig. 1, panel b). Mass spectrometric
evidence, however, did not con¢rm the synthesis of HbSNO in
this case. On the contrary, HbSNO was produced in detect-
able amounts only in the presence of a nitrosothiol system
which was formed only when Cys was preliminary incubated
with the NO produced by iNOS (Fig. 1, panel c). These data
further support the existence of mechanisms involving endog-
enous thiols in the synthesis of HbSNO. In this model Hb
would act as a reversible exchanger of NO in order to regulate
several physiological systems as recently proposed [12].
iNOS is mainly expressed as a consequence of various in-
£ammatory stimuli [23,24]. Under these circumstances, NO
mediates anti-microbial and anti-tumoral activities of the im-
mune system, but long term NO over production causes tissue
damage and other serious diseases [25^27]. These two opposite
e¡ects imply that the organism must regulate NO synthesis
precisely since it is thought that NO can not be stored or
inactivated by conventional mechanisms after release [28] oth-
er than its entrapment by heme ferrous ion of Hb. However,
our data seem to indicate for the ¢rst time the existence of an
e⁄cient mechanism of regulation of the NO level. The control
of NO circulating in blood is essential for the organism, as it
is now well documented the role of this messenger molecule in
the regulation of many physiological mechanisms [29^34].
Therefore, the function of HbSNO is possibly that of sub-
tracting the NO excess from the circulatory system in order
to minimize the damage induced by NO overproduction. In
this way the NO bound would be directed to lungs where it
can be released in the di¡erent pH and pO2 conditions [12].
The formation and stability of the HbSNO were con¢rmed
by mass spectrometry. Mass spectrometric analysis showed
that the half-life of HbSNO is about 24 h and also con¢rmed
that the site of formation of HbSNO by iNOS (LCys-93) is the
same as that involved in the chemical synthesis [15]. The dif-
ferent behavior exhibited by LCys-93 compared to the other
cysteines was in agreement with the already reported in vivo
reactivity of this residue in oxyhemoglobin, which readily
undergoes oxidation to form mixed disulphides and other
thioethers due to its position within the protein quaternary
structure [13]. This di¡erent reactivity of Cys residues in Hb
has been recently observed for another highly reactive electro-
philic agent, methyl bromide [35^38].
Due to the close structural similarity of native and nitro-
sylated species, only di¡ering by the presence of the NO group
over the entire protein/peptide, it seemed reasonable to as-
sume similar behavior in electrospray analysis, as already
shown for methyl bromide [36,39]. Therefore, once the sam-
ples were enzymatically digested to peptides, the reactivity and
the nitrosylation degree of LCys-93 could be measured by
SIM analysis of nitrosylated peptides. By this measurement,
the ratio of modi¢ed and native species could be derived.
In general agreement with our previous experience [15,36],
the synthetic protocol used was not found to signi¢cantly
interfere with the mass spectrometric detection of proteins
and peptides. This analysis can be applied for quantitative
evaluation of nitrosylated proteins. In fact, through peptide
mapping, it is possible to use the methodology here described
for the measurement of the NO level in blood in normal or
pathological conditions.
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